More articles from Oncology, Basic and Translational (Basic Science) Posters

You have access
TIM3-targeted combined-modality radioimmunotherapy in hepatocellular carcinoma
Zhang Chao and Hou Guihua

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1421;
You have access
Al¹⁸F-labeled á-MSH peptide derivative for early detection of melanoma
Hirofumi Hanaoka, Citra Rezza, Aiko Yamaguchi and Yoshito Tsushima

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1417;
You have access
Intra-patient SUL repeatability of background on ¹⁸F-FDG PETCT
Minggang SU, Rang Wang and John Miller

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1415;
You have access
Upregulation of Nicotinic Acetylcholinergic Receptors in Human Lung Adenocarcinomas
Krystal Patel, Edgar Karanjah, Nane Ghazaryan, Shweta Loomba, Gurleen Samra, Mayil Krishnam and Jogeshwar Mukherjee

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1406;
You have access
Poly(ADP-ribose) polymerase 1 (PARP-1) targeted Auger emitter is highly cytotoxic across a panel of ovarian cancer cell lines
Hwan Lee, Adam Mansfield, Paige Burrell, Kuiying Xu, Daniel Pryma, Robert Mach and Mehran Makvandi

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1402;
You have access
Evaluation of fluorine-18 dipeptide as a marker for overexpressed H⁺/peptide transporters
Patrick Carberry, Andrei Molotkov, John Castrillon, Mikhail Doubrovin, Paul Harris and Akiva Mintz

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1400;
You have access
⁸⁹Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo
Yvonne Jauw, Joseph O'Donoghue, JosÃ©e Zijlstra, Otto Hoekstra, C. Willemien Menke-van der Houven van Oordt, Franck Morschhauser, Jorge Carrasquillo, Sonja Zweegman, Neeta Pandit-Taskar, Adriaan Lammertsma, Guus van Dongen, Ronald Boellaard, Wolfgang Weber and Marc Huisman

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1407;
You have access
Modeling targeted lymphodepletion with ¹⁷⁷Lu-radiolabeled CD45 antibody as a preparative regimen prior to adoptive cell therapy
Dale Ludwig, Wojciech Dawicki, Kevin Allen and Ekaterina Dadachova

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1420;
You have access
Bevacizumab radioimmunotherapy in triple-negative breast cancer xenograft
Wenchao Gu, Ryan Yudistiro, Hirofumi Hanaoka and Yoshito Tsushima

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1405;
You have access
4FMFES and FDG-PET of a ER+ uterine cancer mouse xenograft model
Michel Paquette, Serge Phoenix, Roger Lecomte, Brigitte Guerin and Ã‰ric Turcotte

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1418;

Main menu

User menu

Search

More articles from Oncology, Basic and Translational (Basic Science) Posters

Pages